Background. Little is known regarding barriers to guideline adherence in the nephrology community. We set out to identify perceived barriers to evidence-based medicine (EBM) and measurement of continuous quality indicators (CQI) in an international cohort of peritoneal dialysis (PD) practitioners. Methods. Subscribers to an online nephrology education site (Nephrology Now) were invited to participate in an online survey. Nephrology Now is a non-profit, monthly mailing list that highlights clinically relevant articles in nephrology. Four hundred and seventy-five physicians supplying PD care participated in an online survey assessing their use of EBM and CQI in their PD practice. Ordinal logistic regression was utilized to determine relationships between baseline characteristics and EBM and CQI practices. Results. The majority of physicians were nephrologists (89.7%), and 50.4% worked in an academic centre. Respondents were from the following geographic regions: 13.5% Canadian, 24% American, 23.8% European, 4.4% Australian, 5.3% South American, 10.7% African and 12.2% Asian. Adherence to PD clinical practice guidelines were generally strong; however, lower adherence was associated with countries with lower healthcare expenditure, not using personal digital assistant (PDA), the longer the physician had been practising and smaller (<20 patients per centre) PD practice. Conclusions. International variation in guideline adherence may be influenced by a country's healthcare expenditure, physician's PDA use and experience, and size of PD practice which may impact future guideline development and implementation.
Introduction
Given the cost, expertise and time involved in the development of practice guidelines, ensuring they are effectively implemented and incorporated into practice is paramount. A systematic review of barriers to physician adherence to guidelines identified a large number of different barriers with lack of awareness, familiarity and agreement as the most frequently cited barriers [1] . Furthermore, the authors' literature review identified a multitude of potential barriers related to patient factors, environmental factors and attitude [1] . Guideline success will require consideration of the variety of barriers identified. This is especially true for international guidelines as the intended end users include a varied audience with differing patient populations and access to resources.
As the Kidney Disease: Improving Global Outcomes (KDIGO) initiative works towards development of international guidelines in kidney care, little is known about factors that affect adherence to nephrology clinical practice guidelines and barriers to their implementation in the international community. The effects of nephrology guidelines on clinical practice have also been studied by several investigators; however, they were limited to specific regional or geographic territories [2] [3] [4] . Regional practice patterns tend to be more homogenous, often with only one set of guidelines developed specifically for that region. The Dialysis Outcomes and Practice Patterns Study (DOPPS) has clearly demonstrated large international practice variations in haemodialysis patients regarding medication prescription, vascular access and survival [5] [6] [7] [8] [9] . Unfortunately, DOPPS has only investigated differences in haemodialysis practice in North America, Western Europe and Japan, all relatively affluent parts of the world, and no peritoneal dialysis patients were included.
The aim of this study was to identify barriers to guideline adherence. Specifically, we conducted a survey to investigate barriers to evidence-based practice (EBM) and continuous quality initiatives (CQI) in an international cohort of PD practitioners.
Materials and methods
Our survey was distributed to Nephrology Now subscribers. Nephrology Now (www.nephrologynow.com) is a non-profit, online, free email alert service. An independent editorial board selects nephrology-themed jour-nal articles with clinical relevance and incorporates them into a monthly mailing list. The monthly mailing list includes 15-30 articles with title, authors, journal and date of publication, a brief summary, and a link to the article abstract. Full free text is available for~35-40% of all selected articles. As of 1 January 2010, Nephrology Now has >3100 subscribers from 158 countries.
Study population
All subscribers (see Figure 1 ) to the Nephrology Now monthly mailing list were contacted by email in the fall of 2009 and invited to participate in a survey. A total of three reminder emails were sent to all subscribers inviting them to participate. Consent was based on participation in the survey. Regional ethics board approval was obtained.
Survey design. The survey was developed and implemented using SurveyMonkey (www.surveymonkey.com). MMS, DS, ARS, MV and DM were primarily involved in the question development and survey design. Pre-testing was completed by the survey designers and other members of the Nephrology Now editorial board. Survey tracking was completed by MailChimp (www.mailchimp.com). MailChimp allows conductors of email survey studies to determine the number of emails that were opened and unopened, how many were returned (bounce back), and the click (email opening) rate. Evidence-based medicine and continuous quality indicator domains for assessment were selected based on commonalities in peritoneal dialysis guidelines (see Tables 1 and 2 ). The guidelines used were the KDOQI, the CARI, the UK Renal Association and the European Best Practice Association guidelines [10] [11] [12] .
Data analysis. Continuous variables of interest were summarized as mean or medians with standard deviation or intraquartile range as appropriate. Differences in baseline characteristics were determined by Student's t-test for continuous variables and chi-square for dichotomous variables. Only respondents who were physicians and practised PD were included in the final analysis. P-values <0.05 were considered significant. All analyses were conducted using SPSS version 16.0.
The results of the online survey were used to create two scores: one for EBM and one for CQI practices. The response was coded as binary (yes/ no), and a total score was determined for each of EBM and CQI. Univariate and multivariate ordinal regression was used to determine associations between an increasing EBM or CQI score and variables of interest. Variables selected in the final multivariate model were chosen based on the results of the univariate analysis and importance based on previous publications. Model fit was determined by the −2 log likelihood ratio.
The data on the total health expenditure as percentage of gross domestic product were obtained from 2006 core health indicators report at the World Health Organization (WHO website http://apps.who.int/whosis/ database/core.html). The report included health statistics for the 193 WHO member states.
Results
A total of 2147 subscribers were invited to participate, of which 820 surveys were opened and 714 were completed. Two hundred and thirty-nine respondents denied consent, did not practise PD, incompletely filled out the questionnaire or were health professionals other than physicians, resulting in an international sample of 475 physicians included in the final analysis. Development of our study cohort is outlined in Figure 1 . Physician baseline characteristics and peritoneal dialysis practice information are summarized in Table 3 . Approximately three quarters (74.9%) of the respondents were staff physicians, 89% of whom listed Nephrology as their primary specialty. Length of practice was divided into roughly equal quartiles with a large proportion in practice for >20 years. Half (50.1%) of the physicians worked in an academic setting, and nearly three quarters (73.1%) worked in a group practice. Two-thirds (68%) of the physicians indicated that they used personal digital assistants (PDA). The number of prevalent PD patients in physicians' practices varied, with 30.3%, 30.8% and 38.9% of physicians having 10 or less, between 11 and 20, and >20 patients on PD, respectively. Approximately one quarter (24.0%) of the physicians practised in the USA; however, Canada, Europe, Africa and the Middle East, and Asia were also represented, with >50 physicians, or 10% of the total sample, practising in each of these areas (13.5%, 23.8%, 10.7% and 12.2%, respectively). Fewer physicians from Australia/New Zealand and South America were included, with each area representing 4.4% and 5.3% of the total sample, respectively. Tables 1 and 2 summarize the evidence-based and quality indicator areas assessed and list the relevant guidelines where they were included. As summarized in Figure 2 , responses to the EBM portion of the questionnaire indicated that physicians generally follow guideline recommendations quite closely. Greater than 90% of the physicians indicated that they measured Kt/V, estimated GFR and residual renal function (RRF), and used dual antibiotics in empirically treating peritonitis. A slightly lower proportion of physicians used prophylactic antibiotics at the time of PD catheter insertion or antibiotic prophylaxis to prevent exit site infections and peritonitis (77% and 70%, respectively). The lowest proportion (64%) of physicians agreed to using angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB) to preserve residual renal function.
The results of physicians' responses to the CQI portion of the questionnaire are summarized in Figure 3 and again indicate that the majority of physicians follow guideline recommendations on CQI closely. Greater than 90% of the physicians monitored peritonitis rates, had a peritonitis protocol in place, monitored patient satisfaction, estimated RRF, measured Kt/V and monitored technique failure. Approximately 78% of the physicians managed patients as part of a multidisciplinary team, while 88% and 82% of physicians monitored patient quality of life (QOL) and monitored exit site infections, respectively. Table 4 shows the results of univariate analysis of physician and practice characteristics and overall EBM and CQI scores. Statistically significant associations between increasing EBM scores and PDA use, group practice, fewer years in practice, having a greater number of prevalent PD patients, and higher total health expenditures as a percentage of GDP were detected. Between the different geographic areas, only the physicians practising in Australia/New Zealand had significantly lower EBM scores, and no area had significantly higher EBM scores than the mean. No association was found between EBM scores and level of training, number of patients starting PD per year, or working in an academic centre. In univariate analysis, increases in CQI scores were significantly associated with increasing total health expenditures as a percentage of GDP and practising in the USA. Small but significant negative associations were found between CQI scores and physicians practising in Australia, Africa and the Middle East, and Asia.
In multivariate analyses (Tables 5 and 6 ), increases in health expenditures as a percentage of GDP, use of PDA, shorter length of clinical practice and greater number of PD patients in physicians' practice were significantly associated with an increase in EBM score. Health expenditures as a percentage of GDP and a greater number of PD patients remained significantly associated with improving CQI scores. Of note, no geographic areas were significantly associated with EBM or CQI scores in the multivariate analysis. Interaction terms between PDA use and health expenditure and PDA use and length of practice were explored and non-significant (P = 0.134 and P = 0.750, respectively).
Discussion
Inclusion of systematic reviews, improvements in statistical rigour and transparency are key strengths in the devel- The most significant finding of our study is that health expenditures as a percentage of GDP may be linked to guideline adherence. To our knowledge, this is a novel finding with potentially significant implications for international PD guideline development. The implementation of practice guidelines is often associated with a significant cost. A study of one centre of 461 patients in a Canadian tertiary hospital found that the cost of implementing KDO-QI clinical practice guidelines for bone metabolism was greater than half a million US dollars [13] . This cost could be prohibitive in countries with lower health expenditures. Currently, neither CARI, KDOQI nor EBPG guidelines take into consideration costs and benefits of healthcare interventions or determine cost-effectiveness and feasibility of recommendations. Incorporating cost-benefit analyses into clinical practice guidelines is quite controversial, and many authors argue that cost should not be a consideration in writing clinical practice guidelines [14] . A few groups have begun to use cost-benefit analyses in guidelines to limit costly therapies for which the interventions have a limited evidence base. For example, the NICE study in the UK has recommended against the routine use of cinacalcet for the treatment of hyperparathyroidism based on an evidence-based and cost-effectiveness analysis [15] . Unfortunately, in many countries, healthcare expenditures are a fraction of what is spent in countries where regional guidelines currently exist, which may present a significant barrier to the guideline implementation.
Possible barriers to implementation of PD practice guidelines in countries with lower health expenditures may include local practices and generalizability of guidelines to local populations. Current PD guidelines were developed in relatively affluent countries with vastly different healthcare systems than those with lower health expenditures. Physicians may not feel that these guidelines are applicable across different health systems. For instance, a recent interview study of Australian nephrologists revealed that they trusted locally produced guidelines, as they were viewed to be more applicable to their practice setting than international guidelines, of which they were more sceptical [16] . In addition, most of the studies driving guideline recommendations were performed in North America or Europe in primarily Caucasian populations. Significant differences may exist in non-Caucasian populations. For xample, the current Japanese Society for Dialysis Therapy guidelines recommends a target value of 100-110 g/L for haemoglobin in patients with CKD [17] . In contrast, other major societies recommend a target value of 110-120 g/L. This recommendation is based on a study on Japanese patients that showed increased survival at this target, whereas most studies on Caucasians have found increased quality of life and perhaps survival at targets >110 g/L [18] . While this difference is small, it may undermine physician confidence in areas with lower health expenditures about the generalizability of guidelines to their patient population.
The number of prevalent PD patients was significantly associated with adherence to EBM and CQI guidelines. This is consistent with numerous previous studies [19] [20] [21] . Mujais et al. utilizing the POET PD database found that technique failure was increased in centres with <20 PD patients (HR 1.130, P < 0.0001). Similar findings have been reported from studies in Canada and the Netherlands [20, 21] . Many potential barriers could be identified in centres with small PD practices. Knowledge, awareness and familiarity of guidelines may be limited and dependent on a solo physician versus a group of PD practitioners. Several of the CQI guidelines evaluated, such as monitoring rates of adverse events and managing patients as part of an interdisciplinary team would be significantly more difficult and perhaps not economically feasible if physicians have very few PD patients in their practice. Current guidelines do not suggest a minimum number of patients a physician or a centre must manage yearly to maintain proficiency. In contrast, current percutaneous coronary intervention guidelines clearly set a minimum number of coronary angiograms a practitioner or centre must perform annually [22] . These guidelines are based on several studies stating that procedural volume is strongly correlated with complication rates [23] [24] [25] . Whether a minimum number of PD patients per centre are required to maintain competence could be an issue for consideration in future guideline development.
Greater length of clinical practice was also found to be related to lower EBM scores in the current study with ORs of 2.14, 2.19 and 1.81 when comparing nephrologists with 1-5, 6-10 and 11-20 years, respectively, to those with >20 years of clinical experience. A previous study by Irving et al. examined the opinions of Australian nephrologists on guidelines found that older physicians had less favourable attitudes towards guidelines [26] . Irving et al. suggested that this may be due to age being a surrogate marker for greater clinical experience. Our study appears to support this suggestion as nephrologists with greater clinical experience reported significantly lower adherence to clinical practice guidelines. Other studies have reported that recently graduated general practitioners (GPs) are more strongly influenced by clinical practice guidelines and younger GPs are more likely to perform cervical cancer screening in accordance to guidelines [27, 28] . These findings have not been universal as a recent study on screening for oesophageal varices found no association between length of practice and guideline adherence [29] . Guideline adherence therefore may not depend on length of practice but instead on the strength of the underlying evidence, with more experienced practitioners relying more on clinical judgment in the cases where evidence is not as robust.
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In the current study, the use of PDAs also appeared to be associated with greater EBM scores with an OR of 1.55. This is in agreement with several studies that have found that the use of PDA is associated with increased adherence by general practitioners to clinical practice guidelines in the areas of diabetes management and screening for hyperlipidaemia, cervical cancer and colorectal cancer as well as ASA use in patients at high risk for thrombotic events [30, 31] . In addition, the recent GLADHeart study found that GPs with PDAs loaded with clinical decision-making software had greater adherence to ATP III lipid guidelines [32] . In contrast, the ORAMA study found no difference in the management of anaemia in dialysis patients in centres with and without computerized clinical decision software [33] . This raises the possibility that the enhanced convenience of PDA-based versus computer-based clinical decision support systems may result in greater use and adherence to guidelines.
If guidelines are to be applicable internationally, developers may wish to take several factors into account, including differences in health systems and local practice, generalizability of evidence to different populations, and the cost of implementation of guidelines. Based on our findings, the cost of implementation, distribution via new technologies such as PDA, centre size and physician experience may be important considerations when developing international PD guidelines.
International surveys, although limited in many respects, do elicit direct feedback from stakeholders and care providers, and are a quick, simple and inexpensive method of detecting barriers to physician practices. Our study is strengthened by the large number of nephrologists sampled from a diverse range of geographic regions. A variety of EBM and CQI practices were assessed which were derived from a broad base of current practice guidelines. An attempt was made to overcome an inherent weakness of survey study methodology, namely low response rate by the use of a program that identifies the number of emails opened. This allowed for a more robust determination of response rate.
The current study has several significant limitations. The sample of nephrologists was selected from subscribers of the Nephrology Now mailing list. The purpose of this mailing list is to enhance knowledge transfer and to keep practitioners up to date with the latest clinical research. The respondents of the survey therefore were 'self-selected' and may not be representative of all nephrologists. In addition, as with all survey-based research, responses may not necessarily be accurate descriptions of how respondents actually practice but rather how they would ideally practice. Although attempts were made to select EBM and CQI practices that were common in numerous guidelines, this was not always the case. Four of the CQI recommendations were only found in one guideline, thereby limiting the generalizability of these questions internationally. With the widespread dissemination of guidelines over the internet, it is very difficult to determine usage and uptake of guidelines across borders. Finally, North American respondents were over-represented, and a relatively few respondents were from South America and Australia/New Zealand. The relatively small sample size from these latter regions may have yielded results that are not reflective of nephrologists' practice in these areas as a whole.
In conclusion, while self-reported adherence to PD clinical practice guidelines was generally strong, respondents in countries with lower health expenditures reported lower adherence to both CQI and EBM guidelines. This finding may have significant implications in the current effort to develop international PD clinical practice guidelines.
